Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00242827 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
A Phase 2 study, sponsored by Cephalon.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00242827 is a Phase 2 study that was terminated before completion, run by Cephalon.
The verdict
NCT00242827, a Phase 2 study, was terminated before completion, sponsored by Cephalon.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
Interventions
- DRUG Oral CEP-701
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-04 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00242827
The ClinicalTrials.gov registry entry for NCT00242827 describes a study currently listed as terminated, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Cephalon, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral CEP-701 is the first listed.
NCT00242827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00242827 about?
NCT00242827 is a clinical study titled "Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma". An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
What is the current status of trial NCT00242827?
This trial is currently terminated. It is a Phase 2 study. The study started on 2006-04. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00242827?
The interventions under investigation include: Oral CEP-701 (DRUG).
Who is sponsoring clinical trial NCT00242827?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.